Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 PandemicCOVID-19 팬데믹 기간 동안 메타돈 유지 치료 환자에서 C형 간염 미세 제거를 달성하기 위한 협력 의뢰 모델Observational Study Published on 2022-07-272022-09-11 Journal: Viruses [Category] [DOI] 10.3390/v14081637 PMC 바로가기 [Article Type] Observational Study
Applying the RE-AIM framework to evaluate a holistic caregiver-centric hospital-to-home programme: a feasibility study on Carer MattersArticle Published on 2022-07-192022-10-05 Journal: BMC health services research [Category] [DOI] 10.1186/s12913-022-08317-3 PMC 바로가기 [Article Type] Article
Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects무증상/무증상 피험자의 비인두 세균성 미생물총 구성 및 SARS-CoV-2 IgG 항체 유지 관리Article Published on 2022-07-062022-09-11 Journal: Frontiers in Cellular and Infection Microbiology [Category] [DOI] 10.3389/fcimb.2022.882302 PMC 바로가기 [Article Type] Article
Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis유지 투석을 받는 환자의 SARS-CoV-2 백신 3차 접종에 대한 혈청 반응Article Published on 2022-07-012022-09-12 Journal: American journal of kidney diseases : the official [Category] [DOI] 10.1053/j.ajkd.2022.03.002 PMC 바로가기 [Article Type] Article
Evaluation of long-term stability of SARS-CoV-2 nucleic acid extracted from human nasopharyngeal samples인간 비인두 샘플에서 추출한 SARS-CoV-2 핵산의 장기 안정성 평가Article Published on 2022-07-012022-09-11 Journal: Journal of virological methods [Category] [DOI] 10.1016/j.jviromet.2022.114529 PMC 바로가기 [Article Type] Article
TNF-α + CD4 + T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodiesTNF-α + CD4 + T 세포는 COVID-19 외래 환자에서 SARS-CoV-2 특이적 T 세포 반응을 지배하고 내구성 항체와 관련이 있습니다Article Published on 2022-06-212022-09-11 Journal: Cell Reports Medicine [Category] [DOI] 10.1016/j.xcrm.2022.100640 PMC 바로가기 [Article Type] Article
Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy유지 혈액투석을 받고 있는 말기 신질환 환자에서 코로나19 백신 접종의 면역원성: 혼합 및 일치 전략의 효능Article Published on 2022-06-132022-09-12 Journal: Journal of Korean medical science [Category] [DOI] 10.3346/jkms.2022.37.e180 PMC 바로가기 [Article Type] Article
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study브라질에서 2회 용량 1차 프로토콜 및 BNT162b2 이종 부스터(Immunita-001)에서 비활성화된 바이러스(CoronaVac) 백신의 면역원성, 효과 및 안전성: 1년 기간의 후속 조치 4상 연구Clinical Trial Published on 2022-06-092022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.918896 PMC 바로가기 [Article Type] Clinical Trial
Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients예방 접종을 받은 유지 혈액 투석 환자에서 SARS-CoV-2 B.1.617.2 변이체에 의한 체액 반응 및 돌발성 감염Observational Study Published on 2022-06-012022-09-11 Journal: Journal of Nephrology [Category] [DOI] 10.1007/s40620-022-01245-9 PMC 바로가기 [Article Type] Observational Study
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial영국에서 ChAdOx1 nCov-19 또는 BNT162b2 2회 접종 후 3차 추가 접종으로 7가지 COVID-19 백신을 투여한 후 면역원성의 지속성: COV-BOOST 시험의 3개월 분석Clinical Trial Published on 2022-06-012022-09-11 Journal: The Journal of Infection [Category] [DOI] 10.1016/j.jinf.2022.04.018 PMC 바로가기 [Article Type] Clinical Trial